<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The pathogenesis of <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya syndrome</z:e> is unknown; however, previous studies suggested an inflammatory component </plain></SENT>
<SENT sid="1" pm="."><plain>Because <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules mediate <z:mp ids='MP_0001845'>inflammation</z:mp> during <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, we measured the levels of soluble isoforms of the endothelial <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules vascular cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule Type 1, intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule Type 1, and E-selectin in serum and cerebrospinal fluid (CSF) samples from children with <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Serum and CSF samples were obtained from children with <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya syndrome</z:e> (n = 20) and patients with congenital <z:hpo ids='HP_0008443'>spinal deformities</z:hpo> (n = 20) </plain></SENT>
<SENT sid="3" pm="."><plain>Soluble vascular cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule Type 1, intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule Type 1, and E-selectin levels were measured in enzyme-linked immunoassays </plain></SENT>
<SENT sid="4" pm="."><plain>The correlation between the levels of soluble <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules and the Suzuki angiographic classification was analyzed </plain></SENT>
<SENT sid="5" pm="."><plain>CSF/serum albumin index values were also measured, to determine the integrity of the blood-brain barrier </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Compared with the control group, children with <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya syndrome</z:e> exhibited significantly elevated CSF levels of soluble vascular cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule Type 1, intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule Type 1, and E-selectin </plain></SENT>
<SENT sid="7" pm="."><plain>The albumin index for the <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya</z:e> group was 9, which was significantly higher than that for the control group </plain></SENT>
<SENT sid="8" pm="."><plain>However, there were no differences in the serum levels of the three soluble <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules and no correlations between age, Suzuki classification, and serum and CSF levels of <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Our study demonstrates increased CSF levels of soluble endothelial <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules, suggesting that children with <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya syndrome</z:e> have ongoing central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:mp ids='MP_0001845'>inflammation</z:mp>, with slight impairment of the blood-brain barrier </plain></SENT>
<SENT sid="10" pm="."><plain>These soluble <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules may be clinically useful as indicators of this inflammatory process and may provide some insight into this enigmatic disease process </plain></SENT>
</text></document>